BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32486833)

  • 1. Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
    Pandey A; Vaduganathan M; Arora S; Qamar A; Mentz RJ; Shah SJ; Chang PP; Russell SD; Rosamond WD; Caughey MC
    Circulation; 2020 Jul; 142(3):230-243. PubMed ID: 32486833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study.
    Chunawala ZS; Qamar A; Arora S; Pandey A; Fudim M; Vaduganathan M; Bhatt DL; Mentz RJ; Caughey MC
    J Card Fail; 2022 Aug; 28(8):1267-1277. PubMed ID: 35045321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.
    Ather S; Chan W; Bozkurt B; Aguilar D; Ramasubbu K; Zachariah AA; Wehrens XH; Deswal A
    J Am Coll Cardiol; 2012 Mar; 59(11):998-1005. PubMed ID: 22402071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).
    Caughey MC; Avery CL; Ni H; Solomon SD; Matsushita K; Wruck LM; Rosamond WD; Loehr LR
    Am J Cardiol; 2014 Dec; 114(12):1850-4. PubMed ID: 25438912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
    Kolupoti A; Fudim M; Pandey A; Kucharska-Newton A; Hall ME; Vaduganathan M; Mentz RJ; Caughey MC
    Circ Heart Fail; 2021 Dec; 14(12):e008403. PubMed ID: 34702047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
    Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
    Bansal N; Zelnick LR; Scherzer R; Estrella M; Shlipak MG
    Circ Heart Fail; 2024 May; 17(5):e011173. PubMed ID: 38742428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.
    Tsao CW; Lyass A; Enserro D; Larson MG; Ho JE; Kizer JR; Gottdiener JS; Psaty BM; Vasan RS
    JACC Heart Fail; 2018 Aug; 6(8):678-685. PubMed ID: 30007560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.
    Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance.
    Chang PP; Wruck LM; Shahar E; Rossi JS; Loehr LR; Russell SD; Agarwal SK; Konety SH; Rodriguez CJ; Rosamond WD
    Circulation; 2018 Jul; 138(1):12-24. PubMed ID: 29519849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 17. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life.
    Vu K; Claggett BL; John JE; Skali H; Solomon SD; Mosley TH; Williams JE; Kucharska-Newton A; Biering-Sørensen T; Shah AM
    J Am Heart Assoc; 2021 Dec; 10(23):e020094. PubMed ID: 34796739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
    Kristensen SL; Jhund PS; Lee MMY; Køber L; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; McMurray JJV;
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):545-549. PubMed ID: 28948430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.